LABT
LABT clinical trials: Lakewood-Amedex Biotherapeutics Inc.
Every trial on ClinicalTrials.gov where Lakewood-Amedex Biotherapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
LABT on the catalyst calendar · LABT registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jan 2027Sponsor estimate | NCT07565506Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFULakewood-Amedex Inc · Diabetic Foot Ulcers (DFUs) | LABTLead | Phase 2 | Recruiting | Locked | Locked | Locked |
| Jun 2026Sponsor estimate | NCT06020235Nu-3 Gel for Infected Diabetic Foot UlcersLakewood-Amedex Inc · Diabetic Foot Infection | LABTLead | Phase 2 | Not yet recruiting | Locked | Locked | Locked |
| May 18, 2022Actual | NCT05276401Nu-3 Topical Gel for Treatment of Diabetic Foot UlcerLakewood-Amedex Inc · Chronic Diabetic Foot Ulcers | LABTLead | Phase 2 | Terminated | Locked | Locked | Locked |
| Aug 2017Actual | NCT02737722Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes MellitusLakewood-Amedex Inc · Diabetic Foot Infections | LABTLead | Phase 1/Phase 2 | Completed | Locked | Locked | Locked |
- Primary completion Jan 2027Sponsor estimatePhase 2NCT07565506Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFULakewood-Amedex Inc · Diabetic Foot Ulcers (DFUs)RecruitingLABTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2026Sponsor estimatePhase 2NCT06020235Nu-3 Gel for Infected Diabetic Foot UlcersLakewood-Amedex Inc · Diabetic Foot InfectionNot yet recruitingLABTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 18, 2022ActualPhase 2NCT05276401Nu-3 Topical Gel for Treatment of Diabetic Foot UlcerLakewood-Amedex Inc · Chronic Diabetic Foot UlcersTerminatedLABTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2017ActualPhase 1/Phase 2NCT02737722Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes MellitusLakewood-Amedex Inc · Diabetic Foot InfectionsCompletedLABTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner